Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Alzheimer's
MedTech
Abbott pens blood-based Alzheimer's testing deal with ALZpath
Abbott has become the latest company to team up with Alzheimer’s disease blood test developer ALZpath.
Ben Adams
Jun 24, 2026 9:02am
Lilly licenses AlzeCure Alzheimer’s asset for $1B biobucks
Jun 9, 2026 10:16am
Study finds blood test can predict age of Alzheimer's onset
Feb 19, 2026 7:20am
GSK inks 5-year deal with Jackson Lab for neuro research
Feb 18, 2026 3:30pm
Labcorp launches Roche's FDA-cleared Alzheimer's blood test
Feb 12, 2026 7:15am
Quanterix nabs Illumina’s CCO as new leader
Jan 9, 2026 10:45am
